THE FRONTIERS OF
MOLECULAR DIAGNOSTICS
THE FRONTIERS OF
MOLECULAR DIAGNOSTICS
THE FRONTIERS OF
MOLECULAR DIAGNOSTICS
THE FRONTIERS OF
MOLECULAR DIAGNOSTICS
THE FRONTIERS OF
MOLECULAR DIAGNOSTICS
THE FRONTIERS OF
MOLECULAR DIAGNOSTICS
THE FRONTIERS OF
MOLECULAR DIAGNOSTICS
THE FRONTIERS OF
MOLECULAR DIAGNOSTICS
THE FRONTIERS OF
MOLECULAR DIAGNOSTICS
Centre for Novostics, with the meaning of novel diagnostics, aims to push forward the frontier for molecular diagnostics, particularly around prenatal diagnosis and cancer diagnostics.
As the founding Scientific Director of Centre for Novostics, I am excited about the challenges ahead in leading this Centre.
As the founding Scientific Director of Centre for Novostics, I am excited about the challenges ahead in leading this Centre.
Over the last decade, there have been a number of breakthroughs in molecular diagnostics. In 2011, the analysis of fetal DNA in maternal plasma was successfully translated into a clinical non-invasive prenatal test for fetal chromosomal aneuploidies such as Down syndrome. The Epstein-Barr virus (EBV) DNA test for non-invasive screening of nasopharyngeal carcinoma (NPC), which is a common cancer in Hong Kong and the southern part of China, was reported in the New England Journal of Medicine in 2017 as a life-saving tool in asymptomatic persons. The three leading scientists behind these milestones, Professors Dennis Lo, Allen Chan, Rossa Chiu have come together to establish the Centre for Novostics in Hong Kong.
The contents of Centre For Novostics website is subject to change without notice. The Centre accepts no liability for any loss or damage howsoever arising from any use or misuse of or reliance on any information on this website. When you visit this website, we shall have record of your Domain Name Server address and the pages you have visited. This information may be used by us for statistical purpose only.